Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies. Our valuation framework helps you find stocks with the right balance of growth and value characteristics.
As of April 6, 2026, Evogene Ltd Ordinary Shares (EVGN) trades at $0.78, marking a minor 0.15% decline in the current session. This analysis evaluates recent trading trends, key technical levels, and potential near-term scenarios for the biotech stock, with no investment recommendations included. No recent earnings data is available for EVGN at the time of writing, so price action in recent weeks has been driven primarily by broader market sentiment and sector flows rather than company-specific
Is Evogene (EVGN) Stock a Safe Investment | Price at $0.78, Down 0.15% - Profit Potential
EVGN - Stock Analysis
4332 Comments
1221 Likes
1
Datrion
Expert Member
2 hours ago
If only I had seen this in time. 😞
👍 203
Reply
2
Treyon
Regular Reader
5 hours ago
Real-time US stock futures and options market analysis to understand broader market sentiment and directional bias. We provide comprehensive derivatives analysis that often provides early signals for equity market movements.
👍 68
Reply
3
Eustolio
Influential Reader
1 day ago
I understood enough to be confused.
👍 209
Reply
4
Elliyanah
Consistent User
1 day ago
Who’s been watching this like me?
👍 172
Reply
5
Knyomi
Loyal User
2 days ago
Pure excellence, served on a silver platter. 🍽️
👍 196
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.